SLC7A11 and ovarian cancer: Subsequently, the anti-cancer mechanism of lidocaine in ovarian cancer was explored, and it was found that lidocaine promoted iron ptosis through MiR-382-5p/SLC7A11 axis, thereby inhibiting the cell viability and proliferation of ovarian cancer cells, inducing apoptosis, and weakening invasion and migration ability (Sun D. et al., 2021).